ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

USC wins $3.5 million NCI grant.

April 23, 2004

Race And Cancer: “It Would Be Wrong To Design Studies Based On Assumptions That Races Are Biologically Different,” Klausner Says

June 19, 1998

Human Genome Consortium Completes “Working Draft”.

June 30, 2000

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

Smokers May Get Cessation Help From Medicare.

January 14, 2005

DRCCA Board Again Approves Breast Cancer Dietary Study

May 13, 1983